Interpace Diagnostics Group Inc (NASDAQ:IDXG)

0.9099
Delayed Data
As of Apr 20
 +0.0007 / +0.08%
Today’s Change
0.72
Today|||52-Week Range
3.20
-10.79%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Operating ActivitiesNet Income / Starting Line-16.1M-11.4M-8.3M-12.2M
 
 
 
 
 
Depreciation2.4M5.0M4.3M3.7M
 
 
 
 
 
Total Other Cash Flow6.4M15.8M-5.0M605.0K
 
 
 
 
 
Funds From Operations-12.3M8.3M-9.0M-7.9M
 
 
 
 
 
Extraordinary Items0.00-21.6M0.00--
 
 
Funds From/For Other Operating Expenses4.1M6.5M-1.4M7.3M
 
 
 
 
 
Net Cash Flow - Operating Activities-16.4M-19.8M-7.6M-15.3M
 
 
 
 
 
 
InvestingCapital Expenditures-2.9M-353.0K0.00-29.0K
 
 
 
 
Fixed Asset Disposal--26.8M0.00--
 
 
Net Assets From Acquisitions -13.4M0.000.000.00
 
 
Other Investing - Uses-655.0K0.000.000.00
 
 
Net Cash Flow Investing-25.4M26.4M0.00-29.0K
 
 
 
 
 
FinancingShort Term Borrowings0.00---1.3M0.00
 
 
Long Term Borrowings-557.0K-1.6M0.000.00
 
 
 
Long Term Debt Reduction0.00----0.00--
Net Proceeds Stock Sale0.00451.0K1.7M29.9M
 
 
 
 
Common Preferred Redeemed-228.0K-208.0K0.00-28.0K
 
 
 
 
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing20.0M0.00----
 
 
Other Uses - Financing--20.0M475.0K25.0K
 
 
 
 
Net Cash Flow - Financing19.2M-21.4M-101.0K29.9M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----------
 
Net Change In Cash-22.5M-14.8M-7.7M14.6M